OMIC
Income statement / Annual
Last year (2023), Singular Genomics Systems, Inc.'s total revenue was $2.91 M,
an increase of 280.52% from the previous year.
In 2023, Singular Genomics Systems, Inc.'s net income was -$94.82 M.
See Singular Genomics Systems, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
Operating Revenue |
$2.91 M |
$765,000.00 |
$0.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$3.47 M
|
$789,000.00
|
$1.13 M
|
$639,000.00
|
$350,000.00
|
Gross Profit |
-$558,000.00
|
-$24,000.00
|
-$1.13 M
|
-$639,000.00
|
-$350,000.00
|
Gross Profit Ratio |
-0.19
|
-0.03
|
0
|
0
|
0
|
Research and Development Expenses |
$47.76 M
|
$46.20 M
|
$32.66 M
|
$21.25 M
|
$10.48 M
|
General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$6.29 M
|
$2.29 M
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$54.48 M
|
$47.26 M
|
$28.62 M
|
$6.29 M
|
$2.29 M
|
Other Expenses |
$0.00
|
$0.00
|
$405,000.00
|
$0.00
|
$0.00
|
Operating Expenses |
$102.24 M
|
$93.46 M
|
$61.28 M
|
$27.53 M
|
$12.77 M
|
Cost And Expenses |
$105.71 M
|
$94.25 M
|
$61.28 M
|
$27.53 M
|
$12.77 M
|
Interest Income |
$9.08 M
|
$3.37 M
|
$328,000.00
|
$505,000.00
|
$463,000.00
|
Interest Expense |
$1.10 M
|
$763,000.00
|
$846,000.00
|
$718,000.00
|
$17,000.00
|
Depreciation & Amortization |
$7.22 M
|
$6.03 M
|
$1.13 M
|
$639,000.00
|
$350,000.00
|
EBITDA |
-$86.50 M |
-$84.08 M |
-$60.55 M |
-$26.39 M |
-$11.96 M |
EBITDA Ratio |
-29.71
|
-117.8
|
0
|
0
|
0
|
Operating Income Ratio |
-35.31
|
-122.21
|
0
|
0
|
0
|
Total Other Income/Expenses Net |
$7.98 M
|
$2.61 M
|
-$37.49 M
|
-$411,000.00
|
$446,000.00
|
Income Before Tax |
-$94.82 M
|
-$90.88 M
|
-$98.77 M
|
-$27.95 M
|
-$12.32 M
|
Income Before Tax Ratio |
-32.57
|
-118.8
|
0
|
0
|
0
|
Income Tax Expense |
$0.00
|
-$2.61 M
|
$118,000.00
|
$718,000.00
|
$17,000.00
|
Net Income |
-$94.82 M
|
-$88.27 M
|
-$98.89 M
|
-$28.66 M
|
-$12.34 M
|
Net Income Ratio |
-32.57
|
-115.39
|
0
|
0
|
0
|
EPS |
-39.08 |
-37.22 |
-40.95 |
-12.41 |
-5.34 |
EPS Diluted |
-39.08 |
-37.22 |
-40.95 |
-12.41 |
-5.34 |
Weighted Average Shares Out |
$2.43 M
|
$2.37 M
|
$2.41 M
|
$2.31 M
|
$2.31 M
|
Weighted Average Shares Out Diluted |
$2.43 M
|
$2.37 M
|
$2.41 M
|
$2.31 M
|
$2.31 M
|
Link |
|
|
|
|
|